Locust Walk Partners has an established reputation for executing high-value transactions for prominent biopharmaceutical clients. Our team is composed of seasoned operating executives who bring insight, analytics and discipline into every deal process and strategic engagement.
Our offices are located in the biotech hubs of Cambridge, Massachusetts and San Francisco, California.
“We engaged the team at Locust Walk who worked closely with us to build our 3-5 year strategic plan. The end result was transformative and we continue to build off that plan today.”
– Ronald Renaud, President and Chief Executive Officer, Idenix Pharmaceuticals, Inc.
“The Locust Walk team built a solid business case for our topical ibuprofen program and led a competitive bidding process, which culminated in a transaction with one of the world’s leading consumer healthcare companies.”
– Eric Fossel, PhD, CEO and Founder, Strategic Science & Technologies, LLC
“The Locust Walk team’s breadth of technical, financial and negotiating skills helped us to successfully close two highly strategic transactions, while meeting aggressive timelines. We continue to work with them and would strongly recommend them to others.”
– Mark Altmeyer, President & Chief Executive Officer, Otsuka America Pharmaceutical, Inc.
"Key to the summer internship experience with Locust Walk Partners was the firm’s genuine commitment to my own development. I was not just a summer intern, I was a full member of the Locust Walk Team.”
– Neil Swami, 2012 Summer Intern, 2nd year MBA candidate Wharton/UPENN
“At AMAG, we are working with Locust Walk Partners on several BD opportunities, and have found their work to be exceptional. The team is deeply experienced, and brings seasoned insights into all aspects of deal-making activity, including opportunity identification, due diligence activities, valuation and deal structuring. Their focus on adding value is evident in everything they do.”
– Chris White, CBO, AMAG Pharmaceuticals, Inc.
“We were very pleased with the process that Locust Walk Partners ran for the divesture of Actimmune.”
– Larry Kahn, Vice President, Corporate Development, InterMune
“Locust Walk Partners was an active, collaborative member of our ANG1005 deal team. Their commercial assessment and hands-on negotiating support led to improved transaction economics and a successful outcome.”
– Jean-Paul Castaigne, MD, CEO, AngioChem, Inc.
|About | Our Team | Our Services | Engagements | Media Center||© 2013. Locust Walk Partners. The Locust Walk Partners logo is a trademark of Locust Walk Partners, LLC. All rights reserved.|
|Securities offered through Locust Walk Securities, LLC, member FINRA/SIPC.||Web Design: GillFishmanDesign.com Sign In to Edit this Site|